Leucémie myéloïde chronique (LMC) en 2012 = Chronic Myeloid Leukemia (CML) in 2012MICHALLET, M.Oncologie (Paris). 2012, Vol 14, Num 10-11, issn 1292-3818, 70 p.Serial Issue

UN CAS DE MENINGIOME A SYMPTOMATOLOGIE CERVICALEMICHALLET M; PAZAT P.1974; ANN. OTO-LARYNGOL. CHIR. CERVICO-FACIALE; FR.; DA. 1974; VOL. 91; NO 10-11; PP. 618-620Article

Passé et futur de la LMC: allogreffe de CSH, omacetaxine et ponatinib = History and future of CML: allogeneic HSCT, omacetaxine and ponatinibNICOLINI, F. E; MICHALLET, M.Oncologie (Paris). 2012, Vol 14, Num 10-11, pp 613-622, issn 1292-3818, 10 p.Article

Traitement par inhibiteurs de tyrosine-kinase de 2^e génération chez les patients en échec de l'imatinib = Treatment by second-generation tyrosine-kinase inhibitors in patients with imatinib failureETIENNE, G.Oncologie (Paris). 2012, Vol 14, Num 10-11, pp 589-595, issn 1292-3818, 7 p.Article

Inhibiteur de tyrosine-kinase de 1^re génération: résultats à long terme = First-generation tyrosine kinase inhibitor: long-term resultsLEGROS, L.Oncologie (Paris). 2012, Vol 14, Num 10-11, pp 574-578, issn 1292-3818, 5 p.Article

Inhibiteur de tyrosine-kinase de 1^re génération: place des associations = First-generation tyrosine-kinase inhibitors: the role of combination therapyGUILHOT, F.Oncologie (Paris). 2012, Vol 14, Num 10-11, pp 583-588, issn 1292-3818, 6 p.Article

Inhibiteur de tyrosine-kinase de seconde génération: place en 2012 en première ligne = Second-generation tyrosine-kinase inhibitors: their role as a first-line treatment in 2012ROUSSELOT, P.Oncologie (Paris). 2012, Vol 14, Num 10-11, pp 596-600, issn 1292-3818, 5 p.Article

Imatinib en première ligne dans la LMC en 2012: un traitement « dépassé » ? = Chronic myeloid leukemia: is imatinib first line therapy has been in 2012?GIRAUDIER, S.Oncologie (Paris). 2012, Vol 14, Num 10-11, pp 579-582, issn 1292-3818, 4 p.Article

HIGH RATE OF LONG-TERM SURVIVALS IN AML TREATED BY CHEMOTHERAPY AND ANDROGENOTHERAPY. A PILOT STUDYHOLLARD D; SOTTO JJ; BERTHIER R et al.1980; CANCER; USA; DA. 1980; VOL. 45; NO 7; PP. 1540-1548; BIBL. 27 REF.Article

Inhibiteurs de tyrosine-kinase de 2^e génération et associations: perspectives = Second-generation tyrosine-kinase inhibitors and combinations: perspectivesCOITEUX, V.Oncologie (Paris). 2012, Vol 14, Num 10-11, pp 601-605, issn 1292-3818, 5 p.Article

MANAGEMENT OF CLL PATIENTS AFTER CHLORAMBUCIL THERAPY: SPECIAL VALUE OF A SECOND RAI STAGINGMICHALLET M; SOTTO JJ; MOULIN JJ et al.1980; EUROP. J. CANCER; GBR; DA. 1980; VOL. 16; NO 4; PP. 511-517; BIBL. 21 REF.Article

Allogreffes de cellules souches hématopoïétiques = Allogeneic hematopoietic stem cell transplantationsMICHALLET, M.Transfusion clinique et biologique (Paris). 2011, Vol 18, Num 2, pp 235-245, issn 1246-7820, 11 p.Conference Paper

Le diagnostic de la leucémie myéloïde chronique (LMC) en 2012 = Chronic myeloid leukemia (CML) diagnosis in 2012CAYUELA, J.-M; HUGUET, F.Oncologie (Paris). 2012, Vol 14, Num 10-11, pp 561-568, issn 1292-3818, 8 p.Article

Chimiothérapie, interféron et facteurs de croissance dans la séléction des cellules Philadelphie négatives = Chemotherapy, interferon, and growth factors in chronic myelogenous leukaemiaMICHALLET, M; THIEBAUT, A.Hematology and cell therapy (Print). 1998, Vol 40, Num 5, pp 241-246, issn 1269-3286Conference Paper

MYELOME MULTIPLE AVEC INSUFFISANCE RENALE TRAITEE PAR EPURATIONS EXTRA-RENALES: SIX OBSERVATIONSVIALTEL P; ELSENER M; MALLARET MR et al.1980; LYON MED.; ISSN 0024-7790; FRA; DA. 1980; VOL. 244; NO 16; PP. 213-217; ABS. ENG; BIBL. 21 REF.Article

Manifestations digestives de la maladie du greffon contre l'hôte (GVHD) au cours des greffes de moelle osseuse, des transplantations d'organe et des transfusions = Digestive diseases of graft-verus-host disease in bone marrow transplantation, solid organ transplantation and transfusionLI, V; MOLINA, L; MICHALLET, M et al.Gastroentérologie clinique et biologique. 1992, Vol 16, Num 1, pp 29-36, issn 0399-8320Article

DENUTRITION PROTEIQUE PENDANT LA PHASE D'INDUCTION THERAPEUTIQUE DANS LES LEUCEMIES AIGUES ET LYMPHOMES MALINS, CORRECTION PAR L'HYPERNUTRITION PARENTERALE CONTINUEMICHALLET M; LEVERVE X; SERRE JC et al.1979; LYON MED.; FRA; DA. 1979; VOL. 242; NO 18; PP. 439-444; ABS. ENG; BIBL. 20 REF.Article

Chronic leukemia. IMICHALLET, M; TURA, S.Bone marrow transplantation. Supplement (Basingstoke). 1993, Vol 12, Num 4, pp S27-S28, issn 0951-3078Conference Paper

Treatment of a severe extensive cutaneous chronic GVHD after allo-HSCT using glycerolyzed skin allografts and cultured epidermis from the same donorCROCCHIOLO, R; NICOLINI, F.-E; MICHALLET, M et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 8, pp 1153-1155, issn 0268-3369, 3 p.Article

Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT)MICHALLET, A. S; NICOLINI, F; MICHALLET, M et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 6, pp 601-608, issn 0268-3369, 8 p.Article

Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia : Analysis of prognostic factorsREVESZ, D; CHELGHOUM, Y; LE, Q. H et al.Annals of hematology (Print). 2003, Vol 82, Num 11, pp 684-690, issn 0939-5555, 7 p.Article

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma : a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centresGAHRTON, G; SVENSSON, H; LJUNGMAN, P et al.British journal of haematology. 2001, Vol 113, Num 1, pp 209-216, issn 0007-1048Article

Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia : a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)MICHALLET, M; THOMAS, X; JOUET, J. P et al.Bone marrow transplantation (Basingstoke). 2000, Vol 26, Num 11, pp 1157-1163, issn 0268-3369Article

Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma) : a series of 73 patients from the SFGM databaseDHEDIN, N; GIRAUDIER, S; LAPORTE, J. L et al.British journal of haematology. 1999, Vol 107, Num 1, pp 154-161, issn 0007-1048Article

Leucémie lymphdide chronique : attentisme ou éradication ? = Chronic lymphocytic leukemia : wait and see or kill ?BINET, J.-L; DIGHIERO, G; MICHALLET, M et al.Hématologie (Montrouge). 1998, Vol 4, Num 2, pp 148-165, issn 1264-7527Article